Nebivolol for diabetic nerve damage study
Part of Brain & nervous system, Hormones & metabolism, Pain clinical trials.
This study tests whether the drug nebivolol (a type of beta-blocker) can help slow or reverse nerve damage caused by diabetes. It is for people with recent diabetes and confirmed neuropathy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have had diabetes for less than 5 years.
- Your diabetes is stable (HbA1c under 9% for the last 3 months).
- You have nerve damage (neuropathy) from diabetes, confirmed by a nerve test.
- You do not have a very slow heart rate, heart block, severe asthma, or COPD.
- You are not currently taking a beta-blocker or a specific type of calcium channel blocker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the medicine nebivolol can help people with stable chest pain caused by small heart vessel problems, not blocked arteries. You may qualify if you have regular chest pain, normal main arteries, and abnormal small vessel function tests.
This trial tests if adding DLBS1033 to standard treatment can help people with diabetic neuropathy, a nerve condition causing pain or numbness from diabetes. It aims to see if it improves nerve symptoms and quality of life.
This trial tests if finerenone can help people with type 2 diabetes who have early signs of nerve damage affecting their heart and blood vessels (cardiovascular autonomic neuropathy). It aims to see if the drug can improve heart rate control and reduce symptoms.
This trial tests if Levagen+ (a supplement) can reduce nerve pain caused by diabetes. It is for people with type 1 or type 2 diabetes who have significant nerve pain in their feet or legs.
This trial tests whether a combination of alpha lipoic acid (a natural antioxidant) and vitamin B supplements can help relieve nerve pain, numbness, or tingling caused by diabetes. It is for people with type 2 diabetes who have diabetic nerve damage.
This study tests whether umbilical cord stem cells can help people with diabetic nerve damage in their legs who haven't gotten enough relief from standard treatments. It aims to improve symptoms like numbness, pain, and tingling.
Hear when a new Diabetic Neuropathy Peripheral trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.